Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-arm Trial Evaluating the Effectiveness of PCI of de Novo 3-vessel Disease Applying the SYNTAX Score II With Pressure Wire Functional Assessment and IVUS Guidance, Using an Everolimus-eluting Stent With Biodegradable Abluminal Coating

NCT02015832 is registered in ClinicalTrials.gov with ECRI bv as lead sponsor.

NCT NCT02015832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02015832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-arm Trial Evaluating the Effectiveness of PCI of de Novo 3-vessel Disease Applying the SYNTAX Score II With Pressure Wire Functional Assessment and IVUS Guidance, Using an Everolimus-eluting Stent With Biodegradable Abluminal Coating
Lead sponsor
ECRI bv
Phase
Observational
Overall status
Completed
Start date
February 6, 2014
Completion date
February 4, 2021
Enrollment
454 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

3 vessel coronary artery disease, cardiovascular diseases, heart diseases